Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Hill

Showing results (181-190 of 1,343) with videos related to

Pageof 135
Sort By:
British Medical Journal (Clinical Research Ed.)|September 24, 1983
Adjuvant chemotherapy for early breast cancerL A Price, B T Hill
Biochimica Et Biophysica Acta|January 1, 1984
Interactions between clinically effective antitumor drugs and radiation in experimental systemsA S Bellamy, B T Hill
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|December 10, 1983
An experimentally based safe method of administering intensive cancer chemotherapy. Prospects for increased survival in patients with 'solid' tumours during the next decadeL A Price, B T Hill
Obstetrics and Gynecology|August 1, 1982
Radiation risks in pregnancyK L Mossman, L T Hill
Clinical Otolaryngology and Allied Sciences|November 1, 1977
A kinetically based logical approach to the chemotherapy of head and neck cancerL A Price, B T Hill
American Journal of Clinical Oncology|February 1, 1994
Lack of survival advantage in patients with advanced squamous cell carcinomas of the oral cavity receiving neoadjuvant chemotherapy prior to local therapy, despite achieving an initial high clinical complete remission rateB T Hill, L A Price
Biochemical Pharmacology|January 1, 1970
The selectivity of action of alkylating agents and drug resistance. 3. The uptake and degradation of alkylating drugs by Yoshida ascites sarcoma cells in vitroK R Harrap, B T Hill
Cancer Letters|August 1, 1983
In vitro neurotoxic assessment of antitumour drugsS A Whatley, B T Hill
British Journal of Urology|December 1, 1983
The colonic conduit: a better method of urinary diversion?J T Hill, P G Ransley
Gerontology|January 1, 1978
Studies on the degradation of ageing chromatin DNA by nuclear and cytoplasmic factors and deoxyribonucleasesB T Hill, R D Whelan
Pageof 135

Showing results (181-190 of 1,343) with videos related to

Sort By:
Pageof 135
British Medical Journal (Clinical Research Ed.)|September 24, 1983
Adjuvant chemotherapy for early breast cancerL A Price, B T Hill
Biochimica Et Biophysica Acta|January 1, 1984
Interactions between clinically effective antitumor drugs and radiation in experimental systemsA S Bellamy, B T Hill
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|December 10, 1983
An experimentally based safe method of administering intensive cancer chemotherapy. Prospects for increased survival in patients with 'solid' tumours during the next decadeL A Price, B T Hill
Obstetrics and Gynecology|August 1, 1982
Radiation risks in pregnancyK L Mossman, L T Hill
Clinical Otolaryngology and Allied Sciences|November 1, 1977
A kinetically based logical approach to the chemotherapy of head and neck cancerL A Price, B T Hill
American Journal of Clinical Oncology|February 1, 1994
Lack of survival advantage in patients with advanced squamous cell carcinomas of the oral cavity receiving neoadjuvant chemotherapy prior to local therapy, despite achieving an initial high clinical complete remission rateB T Hill, L A Price
Biochemical Pharmacology|January 1, 1970
The selectivity of action of alkylating agents and drug resistance. 3. The uptake and degradation of alkylating drugs by Yoshida ascites sarcoma cells in vitroK R Harrap, B T Hill
Cancer Letters|August 1, 1983
In vitro neurotoxic assessment of antitumour drugsS A Whatley, B T Hill
British Journal of Urology|December 1, 1983
The colonic conduit: a better method of urinary diversion?J T Hill, P G Ransley
Gerontology|January 1, 1978
Studies on the degradation of ageing chromatin DNA by nuclear and cytoplasmic factors and deoxyribonucleasesB T Hill, R D Whelan
Pageof 135